12년 미용기 집중 - 안마기 연구 개발 & 제조 - 심천시 홍하전자상거래유한공사
위치：
홈 >
Data interpretation of the "2022 New Oxygen Medical Aesthetics Industry White Paper" source: Xinhua News Agency
Data interpretation of the "2022 New Oxygen Medical Aesthetics Industry White Paper" source: Xinhua News Agency
2023-03-17 09:45
2022 So-Young Medical Aesthetics White Paper Data Insights
Over the next decade, China's medical aesthetics industry will reshape: big chains, big capital, big brands, full compliance, mass accessibility, mature-aged consumers, dual-tech & dual-brand engines. From surgery-dominant to light aesthetics, rational consumption replaces excess marketing.
Frost & SullivanSo-Young Data Research InstituteiResearchSouyoung Qualitative Research (N=313)China Consumers AssociationWolters Kluwer
🔗 Source: Official WeChat Account "Semiconductor Industry Watch" (icbank) | Written by Shao Yiqi | Image: Visual China | White Paper Full Version (Mirror)
🏆 Market Shift
Non-Surgical Dominance
84% online transaction volume
84%
In 2022, non-surgical orders accounted for 84% on So-Young platform, up from 62% in 2017. Light aesthetics prevail.
Surgical order share (2017→2022)38% → 16%
Source: So-Young Data Institute
🏢 Industry Restructuring
Big Chains & Capital
Only 3 investment deals in 2022
3 deals
Venture capital turned cautious, yet compliance drives chain acceleration. Top players consolidate regional clinics.
- ✔ Rising customer acquisition costs
- ✔ Branded groups dominate
- ✔ Compliance reshapes midstream
White Paper: Big Chain + Big Compliance trends
💰 Mass Accessibility
Affordability Era
Average ticket price declines YoY
Overall avg. spend (2018-2022)Steadily down 📉
Energy-based devicesLowest threshold
Photofacial, thermage become entry-level, boosting first-time users.
So-Young Data Institute | Price trend analysis
👥 Demographics Shift
Mature Majority
Users aged 26+ exceed 50%
50.3%
In H1 2022, consumers above 26 became the backbone. Energy-based devices are top choice (38%).
Favorite categoryEnergy-based 38% | Injectables 30%
Beijing Fengli Lige: Tech iteration drives acceptance
🔄 Repeat Purchase
High Frequency
53%+ users consume ≥2 times/year
53.6%
Over half of users visit twice or more; those aged 41+ show heaviest frequency (17% consume 5+ times).
5+ times (41+ group)17.02%
So-Young H1 2022 multi-frequency analysis
💃 Gender Power
She‑economy
Female users 89.2%
Female paid users89.17%
Male paid users10.83% (growing)
Male aesthetics awareness rising, new market segment emerges.
So-Young Gender Distribution 2022
🛡️ Risk Awareness
Medical Insurance Surge
Online policies +29.9% YoY
+29.9%
More consumers willing to cover medical risks; policy upgrades increased 24% vs 2021.
So-Young Insurance Data
🏙️ Urban Landscape
New Tier‑1 Rise
Orders surpass Tier‑1 cities in 2022
Order share (New T1)28.2% vs 24.6% (T1)
GMV share (New T1)28.5% leading nationwide
Chengdu, Hangzhou, Chongqing drive consumption upgrade.
So-Young City-Level Comparison 2021-2022
📈 Project Concentration
Anti-Aging Leads
Top 10 projects drive 70% GMV
70%
"Skin tightening & anti-aging" ranks #1, rising fast over 4 years.
Anti-aging GMV share~18% platform total
So-Young GMV concentration 2019-2022
🔪 Surgical Market
Surgical Under Pressure
Eye procedures drop >50%
Eye comprehensive orders (2022 vs 2021)-54.6%
Incisional double eyelid-51.2%
Non-surgical substitution intensifies, but leg/ nose surgeries retain niche.
2022 surgical user data / Top eye procedures
⚙️ Strategic Drivers
Dual Tech & Brand + Full Compliance
Mature growth cycle: big compliance, mass accessibility, mature demography
📜 Compliance Upgrade
Higher standards, accelerated chain consolidation
Higher standards, accelerated chain consolidation
🚀 Tech+Brand Dual Core
Energy devices + novel injectables drive innovation
Energy devices + novel injectables drive innovation
🧠 Rational Consumption
Insurance penetration + risk awareness
Insurance penetration + risk awareness
China Plastic & Aesthetic Association / Souyoung Management Consulting
🧠 SUMMARY MIND MAP
📊 Non-Surgical Wave
- 84% order share (2022)
- Light aesthetics mainstream
- Lower average ticket
👥 Mature Consumers
- 26+ users >50%
- High frequency (≥2 times 53%)
- Anti-aging #1 GMV driver
🏙️ Urban Shift
- New Tier-1 surpass Tier-1
- Strong growth in Chengdu, Hangzhou
🔧 Industry Trends
- Big chains + Big capital
- Full compliance + dual-tech
- Insurance & rational consumption
Market rebounding post-pandemic · Mature growth phase · China medical aesthetics enters high-quality era
💬 Industry & Reader Comments 10 perspectives
Dr. Emily Zhou, Dermatologist 2h ago
The 84% non-surgical share confirms what we see in clinics — energy devices and injectables dominate. Great data rigor.
Kevin Zhang, Investment Analyst 5h ago
Only 3 midstream funding rounds in 2022, but chain consolidation is accelerating. Compliance creates moats for leaders.
Sophia Liu, Beauty Tech yesterday
Anti-aging jumping to #1 GMV is no surprise. Consumers are proactive about skin tightening earlier.
New Tier-1 Clinic Owner yesterday
Order volume in our Chengdu clinic has surpassed Shanghai. The white paper captures the exact trend.
James Wang, Insurance Advisor 1 day ago
29.9% policy growth shows maturing risk perception — medical aesthetic insurance will be standard.
Dr. Maya R., Plastic Surgeon 1 day ago
Surgical procedures down >50% for eyes, but combination treatments (surgery+energy) remain relevant.
Lucy He, Consumer Panel 2 days ago
I used to hesitate due to cost, now photofacial is affordable. Mass accessibility really works.
VC Partner, Healthcare Fund 2 days ago
Big capital might be quiet now but leading groups are positioning for the compliance-driven wave.
Aesthetic Nurse Bella 3 days ago
Mature users (41+) with 5+ visits per year — loyalty & high lifetime value is incredible.
Regulatory Expert, Weikang 3 days ago
Double-tech & brand strategy will separate quality players from the rest. Excellent summary.
© 2022 So-Young Medical Aesthetics White Paper · Frost & Sullivan / So-Young Data Institute / iResearch | English translation for insight purpose only | Data-driven future of China aesthetics
면책: 이 기사는 인터넷에 있는 원래 / 재게시된 기사에서 출처되었습니다.이 기사에서 표현된 견해는 저자만 대표하며 웹사이트의 위치를 대표하지 않습니다.이 웹사이트는 정보 저장 공간 서비스만 제공하고 있으며 법적 책임을 지지 않습니다.콘텐츠가 위반/불법 위반/사실적 불일치를 초래하는 경우, 관련 정보를honghebusiness@foxmail.com불만에 대한 피드백.확인하면 즉시 처리하십시오!이 웹사이트 링크 https://www.honghebusiness.com/kor/news-industry/3433.html
첨부 파일 다운로드(1)：
이름：
내용：
인증 코드： 
의견을 제출하려면
댓글
위치：
홈 >
Data interpretation of the "2022 New Oxygen Medical Aesthetics Industry White Paper" source: Xinhua News Agency